TLN-4601

· Thallion Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLN-4601, covering 2009-12-30 to 2009-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme [Phase 2]